Friess Associates’s Aspira Women's Health Inc. Common Stock AWH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-92,136
Closed -$4.49M 109
2021
Q3
$4.49M Sell
92,136
-4,054
-4% -$251K 1.89% 17
2021
Q2
$8.11M Buy
96,190
+4,475
+5% +$384K 3.06% 2
2021
Q1
$9.29M Buy
91,715
+18,339
+25% +$2.02M 3.61% 4
2020
Q4
$7.38M Buy
73,376
+18,176
+33% +$1.21M 0.54% 51
2020
Q3
$2.55M Buy
+55,200
New +$2.83M 0.22% 72

Other funds holding AWH

Friess Associates's AWH Position: Q4 2021 in Review

Friess Associates sold out of Aspira Women's Health Inc. Common Stock (AWH) in Q4 2021, closing a stake of 92,136 shares — an estimated $4.49M sold.

Friess Associates first reported a position in AWH in Q3 2020 and held it in 5 quarters. The position peaked at $9.29M in Q1 2021. 98 funds tracked by Wall St. Rank hold AWH as of Q4 2021.

  • Friess Associates reported no remaining Aspira Women's Health Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Friess Associates sold 92,136 Aspira Women's Health Inc. Common Stock shares in Q4 2021, an estimated $4.49M.
  • Friess Associates first reported a position in Aspira Women's Health Inc. Common Stock in Q3 2020 and held it in 5 quarters.
  • Friess Associates's Aspira Women's Health Inc. Common Stock position peaked at $9.29M in Q1 2021.
  • 98 funds tracked by Wall St. Rank held Aspira Women's Health Inc. Common Stock as of Q4 2021.

Based on Friess Associates's 13F filing for Q4 2021, filed 11 Feb 2022.